PTC Therapeutics, Inc.

Historical 13F Holders

Symbol
PTCT
CUSIP
69366J200
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 69366J200 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 14.8% 12/4/2025
Event 11/30/2025
Janus Henderson Group PLC 13G/A 8.7% 5/15/2026
Event 3/31/2026
State Street Corp 13G 6.6% 11/10/2026
Event 9/30/2026
Wellington Management Group LLP 13G
6.3% 11/16/2026
Event 9/30/2026
Vanguard Portfolio Management LLC 13G 5.9% 4/29/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.2% 4/30/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Armistice Capital, LLC 13G/A
Amended under CUSIP 50127T109 on 8/14/2025
6.9% 5/15/2025
Event 3/31/2025
Camber Capital Management LP 13G/A
4.2% 2/14/2025
Event 12/31/2024
Toronto Dominion Bank 13G/A 3.7% 5/15/2026
Event 3/31/2026
RTW Investments, LP 13G/A
1.9% 11/16/2026
Event 9/30/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 362 93.9 M $6.09B
2026 Q2 386 101 M $8.20B
2026 Q1 357 95.5 M $6.51B
2025 Q4 357 92.7 M $7.04B
2025 Q3 299 82.7 M $5.07B
2025 Q2 287 79.9 M $3.90B
2025 Q1 263 78.8 M $4.02B
2024 Q4 244 77.7 M $3.51B
2024 Q3 205 78.8 M $2.92B
2024 Q2 201 79.8 M $2.44B
2024 Q1 187 85.2 M $2.48B
2023 Q4 177 84.6 M $2.34B
2023 Q3 185 81.7 M $1.84B
2023 Q2 209 81.1 M $3.30B
2023 Q1 207 78.5 M $3.81B
2022 Q4 208 76.9 M $2.94B
2022 Q3 217 76.3 M $3.83B
2022 Q2 185 74.1 M $2.97B
2022 Q1 188 74.5 M $2.77B
2021 Q4 181 75.4 M $3.00B
2021 Q3 184 74.6 M $2.78B
2021 Q2 189 74.2 M $3.14B
2021 Q1 212 74.1 M $3.52B
2020 Q4 220 73.2 M $4.46B
2020 Q3 203 71.5 M $3.34B
2020 Q2 209 68.8 M $3.47B
2020 Q1 206 64.3 M $2.87B
2019 Q4 211 61.1 M $2.94B
2019 Q3 191 61.9 M $2.09B
2019 Q2 182 58.4 M $2.63B
2019 Q1 182 58.6 M $2.21B
2018 Q4 170 48.8 M $1.67B
2018 Q3 185 46.9 M $2.20B
2018 Q2 168 43.1 M $1.45B
2018 Q1 152 42.7 M $1.15B
2017 Q4 128 38.1 M $636M
2017 Q3 135 35.7 M $715M
2017 Q2 114 33.5 M $615M
2017 Q1 118 31.5 M $310M
2016 Q4 128 28.7 M $313M
2016 Q3 119 29.2 M $409M
2016 Q2 121 28.6 M $202M
2016 Q1 123 29.4 M $190M
2015 Q4 149 36.3 M $1.18B
2015 Q3 168 33.1 M $896M
2015 Q2 159 32.6 M $1.57B
2015 Q1 160 31.5 M $1.92B
2014 Q4 133 28.4 M $1.47B
2014 Q3 99 24.4 M $1.07B
2014 Q2 84 23.0 M $601M
2014 Q1 65 23.0 M $600M